Publications by authors named "Roland R Brandt"

Article Synopsis
  • Echocardiography is essential for planning electrophysiological procedures by assessing heart structure and function.
  • It helps evaluate left atrial remodeling, which is linked to the risk of developing atrial fibrillation and predicting its recurrence after treatment.
  • The procedure also assists in excluding left atrial clots and guiding necessary interventions, like pericardiocentesis, while providing critical information for managing patients with systolic dysfunction.
View Article and Find Full Text PDF

Aims: Cardiac resynchronization therapy (CRT) utilizing biventricular pacing (BVP) is a promising treatment modality for symptomatic patients with chronic left ventricular (LV) systolic dysfunction and intraventricular conduction delay. Clinical studies have shown short-term improvement in contractile function and mid-term improvement in clinical status with CRT. The objective of this study was to evaluate the haemodynamic consequences of temporary interruption of CRT after long-term stimulation.

View Article and Find Full Text PDF

Objectives: The purpose of the present study was to evaluate whether magnetic resonance (MR) planimetry of the aortic valve area (AVA) may prove to be a reliable, non-invasive diagnostic tool in the assessment of aortic valve stenosis, and how the results compare with current diagnostic standards.

Background: Current standard techniques for assessing the severity of aortic stenosis include transthoracic and transesophageal echocardiography (TEE) as well as transvalvular pressure measurements during cardiac catheterization.

Methods: Forty consecutive patients underwent cardiac catheterization, TEE, and MR.

View Article and Find Full Text PDF

Transcatheter closure of atrial septal defect (ASD) and patent foramen ovale (PFO) using the Amplatzer septal occluder (AGA Medical, Minneapolis, Minn) is an alternative to surgical closure. There are only limited data on the thrombogenic potential of the device. Thirty-seven patients (14 men, 23 women) underwent device closure of their ASD (n = 21) or PFO (n = 16) at a mean age of 47 +/- 14 years (range, 18-72).

View Article and Find Full Text PDF